We provide 1 form of Carfilzomib
Carfilzomib
868540-17-4
|
719.426
|
6.396
Carfilzomib is a proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma.
CFZ | PR 171 | PR-171 | carfilzomib | kyprolis
Carfilzomib is a proteasome inhibitor used either alone or in conjunction with a chemotherapy regimen to treat patients with relapsed or refractory multiple myeloma.
CFZ | PR 171 | PR-171 | carfilzomib | kyprolis
$84/5 mg
(EBC)
1
We provide 0 compound for Carfilzomib